Luptakova Katarina has filed 19 insider transactions across 1 company since January 2024.
Most recent transaction: a option exercise of 16625 shares of Xilio Therapeutics, Inc. ($XLO) on January 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 1, 2026 | Xilio Therapeutics, Inc. | $XLO | Luptakova Katarina | CHIEF MEDICAL OFFICER | M | Common Stock | 16625 | $0.00 | 33,250.0000 | 144,106,869 | 100.00% | 0.01% |
| Jan. 1, 2026 | Xilio Therapeutics, Inc. | $XLO | Luptakova Katarina | CHIEF MEDICAL OFFICER | M | Restricted Stock Units | 16625 | $0.00 | 33,250.0000 | 144,106,869 | 33.33% | 0.01% |
| Dec. 31, 2025 | Xilio Therapeutics, Inc. | $XLO | Luptakova Katarina | CHIEF MEDICAL OFFICER | A | Stock Option (right to buy) | 451885 | $0.00 | 451,885.0000 | 144,106,869 | 9999.99% | 0.31% |
| Nov. 21, 2025 | Xilio Therapeutics, Inc. | $XLO | Luptakova Katarina | CHIEF MEDICAL OFFICER | A | Stock Option (right to buy) | 15000 | $0.00 | 15,000.0000 | 144,106,869 | 9999.99% | 0.01% |
| Nov. 21, 2025 | Xilio Therapeutics, Inc. | $XLO | Luptakova Katarina | CHIEF MEDICAL OFFICER | A | Stock Option (right to buy) | 35000 | $0.00 | 35,000.0000 | 144,106,869 | 9999.99% | 0.02% |
| Nov. 21, 2025 | Xilio Therapeutics, Inc. | $XLO | Luptakova Katarina | CHIEF MEDICAL OFFICER | D | Stock Option (right to buy) | 25000 | $0.00 | 0.0000 | 144,106,869 | 100.00% | 0.02% |
| Nov. 21, 2025 | Xilio Therapeutics, Inc. | $XLO | Luptakova Katarina | CHIEF MEDICAL OFFICER | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 144,106,869 | 9999.99% | 0.02% |
| Nov. 21, 2025 | Xilio Therapeutics, Inc. | $XLO | Luptakova Katarina | CHIEF MEDICAL OFFICER | D | Stock Option (right to buy) | 106000 | $0.00 | 0.0000 | 144,106,869 | 100.00% | 0.07% |
| Nov. 21, 2025 | Xilio Therapeutics, Inc. | $XLO | Luptakova Katarina | CHIEF MEDICAL OFFICER | A | Stock Option (right to buy) | 106000 | $0.00 | 106,000.0000 | 144,106,869 | 9999.99% | 0.07% |
| Nov. 21, 2025 | Xilio Therapeutics, Inc. | $XLO | Luptakova Katarina | CHIEF MEDICAL OFFICER | A | Stock Option (right to buy) | 625000 | $0.00 | 625,000.0000 | 144,106,869 | 9999.99% | 0.43% |
| Nov. 21, 2025 | Xilio Therapeutics, Inc. | $XLO | Luptakova Katarina | CHIEF MEDICAL OFFICER | D | Stock Option (right to buy) | 44210 | $0.00 | 0.0000 | 144,106,869 | 100.00% | 0.03% |
| Nov. 21, 2025 | Xilio Therapeutics, Inc. | $XLO | Luptakova Katarina | CHIEF MEDICAL OFFICER | A | Stock Option (right to buy) | 44210 | $0.00 | 44,210.0000 | 144,106,869 | 9999.99% | 0.03% |
| Nov. 21, 2025 | Xilio Therapeutics, Inc. | $XLO | Luptakova Katarina | CHIEF MEDICAL OFFICER | D | Stock Option (right to buy) | 15000 | $0.00 | 0.0000 | 144,106,869 | 100.00% | 0.01% |
| Nov. 21, 2025 | Xilio Therapeutics, Inc. | $XLO | Luptakova Katarina | CHIEF MEDICAL OFFICER | D | Stock Option (right to buy) | 35000 | $0.00 | 0.0000 | 144,106,869 | 100.00% | 0.02% |
| Jan. 1, 2025 | Xilio Therapeutics, Inc. | $XLO | Luptakova Katarina | CHIEF MEDICAL OFFICER | M | Common Stock | 16625 | $0.00 | 16,625.0000 | 63,465,063 | 9999.99% | 0.03% |
| Jan. 1, 2025 | Xilio Therapeutics, Inc. | $XLO | Luptakova Katarina | CHIEF MEDICAL OFFICER | A | Stock Option (right to buy) | 200000 | $0.00 | 200,000.0000 | 63,465,063 | 9999.99% | 0.32% |
| Jan. 1, 2025 | Xilio Therapeutics, Inc. | $XLO | Luptakova Katarina | CHIEF MEDICAL OFFICER | M | Restricted Stock Units | 16625 | $0.00 | 49,875.0000 | 63,465,063 | 25.00% | 0.03% |
| May 1, 2024 | Xilio Therapeutics, Inc. | $XLO | Luptakova Katarina | CHIEF MEDICAL OFFICER | A | Stock Option (right to buy) | 59333 | $0.00 | 59,333.0000 | 0 | 9999.99% | 0.00% |
| Jan. 1, 2024 | Xilio Therapeutics, Inc. | $XLO | Luptakova Katarina | CHIEF MEDICAL OFFICER | A | Restricted Stock Units | 66500 | $0.00 | 66,500.0000 | 0 | 9999.99% | 0.00% |